Bristol pharmaceuticals startup bought for £623 million
Imported from official source
University spin-out - supported by UK Research and Innovation funding - acquired to develop 'groundbreaking' treatment for diabetes.
This version
- Version
- 1 of 1
- Recorded
- September 20, 2026 19:53
- Change
- Initial
- Content hash
e834318cef44fb5fd527a57b6382cff5- All versions
- Revision history